Index Ventures

Index Ventures is dedicated to working with entrepreneurs who have the drive and ability to build world-class technology companies that can become global players in their market. After reading the information in this section, please read the sections regarding what we like, how we work and who gets our attention.

Contact Details: 2, rue de Jargonnant Geneva 1207 Switzerland Tel: (+41) 22 737 0000 Fax: (+41) 22 737 0099 Email: sayula@indexventures.com WWW: www.indexventures.com/

Press Releases on Index Ventures:
NovoCure, Ltd., Announces the Closing of a Financing Round Including New Investors Pfizer Inc, Johnson & Johnson Development Corporation and Index Ventures	28th September, 2009	NovoCure, Ltd.	NEW YORK, Sept. 28 /PRNewswire/ -- NovoCure, Ltd., a privately held medical device company focused on developing the Novo-TTF device, a non-invasive portable medical device for the treatment of cancer
Funxional Successfully Completes Initial Clinical Trial of FX125L, an Anti-Inflammatory Drug With a Novel Mechanism of Action	8th July, 2009		CAMBRIDGE, England, July 8 /PRNewswire/ -- Funxional Therapeutics Ltd (Funxional) has announced today the successful completion of the first Phase I study with FX125L, an orally available small
GlycoVaxyn AG Raises CHF 25 Million in Financing Led by Edmond de Rothschild Investment Partners	5th March, 2009		SCHLIEREN, Switzerland, March 5 /PRNewswire/ -- GlycoVaxyn, a pioneer in the development of innovative conjugated vaccines, today announced the successful closing of a CHF25 million (ca. US$22 million
Index Ventures Closes Euro 350 Million Early Stage Fund	3rd March, 2009		LONDON, March 3 /PRNewswire/ -- Index Ventures today announced the closing of a euro 350 million early stage fund, Index Ventures V. The fund is dedicated to early stage and seed investments in the
Global Life Science Ventures announces investment into CareX	1st November, 2001	Global Life Sciences	Global Life Science Ventures announces investment into CareX Zug/London/Munich, 08 March 2004 - Global Life Science Ventures (GLSV) today announced that it has made an investment into CareX SA,

BioNews Results for Index Ventures:
BioXell Welcomes Cosmos Proposed $40.9M Acquisition	Genetic Engineering News:  Nov 18 2009 8:21PM Matching: index ventures
Biotech Cosmo Pharmaceuticals S.p.A. Aims to Buy Rival BioXell S.p.A. for $41 Million	BioSpace:  Nov 18 2009 5:49PM Matching: index ventures
XTEN Data From Amunix and Versartis Featured in Nature Biotechnology as a Novel Platform for Increasing Serum Half-Life of Protein Therapeutics	Earthtimes.org:  Nov 15 2009 7:40PM Matching: index ventures
PanGenetics Announces Acquisition by Abbott of PG110 anti-NGF Antibody to Treat Chronic Pain	Pharma Live:  Nov 14 2009 1:00AM Matching: index ventures
Abbott to acquire the global rights to PanGenetics' new therapeutic for treatment of chronic pain	News-Medical.Net:  Nov 13 2009 7:23AM Matching: index ventures
Promote your company here: BioNewsCast - Press Release Distribution	→View more Index Ventures news.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 200 times since April 2007, the link to the organisation's website has been followed 38 times

Search for more companies in Geneva

Search for more companies in

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Index Ventures